Life Sciences and Emerging Growth Companies

Rubin and Rudman represents a broad spectrum of life science companies in all stages of research, development, and commercialization of therapeutics, medical devices, products and services. Our lawyers counsel a broad range of young companies on the cutting edge of technology, and engaged in developing some of the most exciting new products and services.

Our focus includes:

  • Intellectual property
  • License negotiations
  • Capital formation
  • Venture capital financing
  • Mergers and acquisitions
  • Securities regulation
  • Private offerings
  • Structuring strategic alliances
  • Joint ventures
  • Other legal and business issues

Clients benefit from our advice and negotiation of agreements for licensing,  original equipment manufacturers (OEMs), value-added resellers (VARs), hosting, development, confidentiality, material transfer, clinical trials, marketing and distribution.

In the dynamic, highly regulated and increasingly complex and diverse life sciences and technology worlds, our seasoned legal professionals understand the constraints of corporate budgets and the limits of individual financing. We also understand the pressures faced by entrepreneurs as they seek funding, set up operations and go to marketing.

We make available to our life sciences and emerging growth company clients the resources of our colleagues, including lawyers in our Labor and EmploymentReal Estate, and Litigation practice groups.